Daniel R. Scoles

2.7k total citations
58 papers, 1.9k citations indexed

About

Daniel R. Scoles is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Daniel R. Scoles has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 20 papers in Neurology. Recurrent topics in Daniel R. Scoles's work include Genetic Neurodegenerative Diseases (24 papers), Mitochondrial Function and Pathology (17 papers) and RNA Research and Splicing (14 papers). Daniel R. Scoles is often cited by papers focused on Genetic Neurodegenerative Diseases (24 papers), Mitochondrial Function and Pathology (17 papers) and RNA Research and Splicing (14 papers). Daniel R. Scoles collaborates with scholars based in United States, Canada and United Kingdom. Daniel R. Scoles's co-authors include Stefan M. Pulst, Warunee Dansithong, Sharan Paul, Eric Vallabh Minikel, Duong P. Huynh, Beth Y. Karlan, Stefan-M. Pulst, Karla P. Figueroa, Karla P. Figueroa and John E. Graves and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Daniel R. Scoles

53 papers receiving 1.9k citations

Peers

Daniel R. Scoles

CMN

NEURO

Mehrdad Khajavi United States

Carol Hicks United States

Linda J. Valentijn Netherlands

Christian Beetz Germany

Anindya Sen United States

Mark W. Kankel United States

Peter Hackman Finland

N J Scavarda United States

John E. Landers United States

Gilbert Bernier Canada

Mehrdad Khajavi United States

Daniel R. Scoles

1.5k ×1.3

984 ×1.4

CMN

517 ×0.9

NEURO

219 ×1.0

191 ×1.0

Citations per year, relative to Daniel R. Scoles Daniel R. Scoles (= 1×) peers Mehrdad Khajavi

Countries citing papers authored by Daniel R. Scoles

Since Specialization

Citations

This map shows the geographic impact of Daniel R. Scoles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Scoles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Scoles more than expected).

Fields of papers citing papers by Daniel R. Scoles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Scoles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Scoles. The network helps show where Daniel R. Scoles may publish in the future.

Co-authorship network of co-authors of Daniel R. Scoles

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Scoles. A scholar is included among the top collaborators of Daniel R. Scoles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Scoles. Daniel R. Scoles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scoles, Daniel R., Anton Simeonov, Thomas S. Dexheimer, et al.. (2025). Identifying Molecular Properties of Ataxin-2 Inhibitors for Spinocerebellar Ataxia Type 2 Utilizing High-Throughput Screening and Machine Learning. Biology. 14(5). 522–522.

Scoles, Daniel R. & Stefan M. Pulst. (2024). Control of innate immunity and lipid biosynthesis in neurodegeneration. Frontiers in Molecular Neuroscience. 17. 1402055–1402055. 4 indexed citations

Figueroa, Karla P., Collin J. Anderson, Sharan Paul, et al.. (2023). Slc9a6 mutation causes Purkinje cell loss and ataxia in the shaker rat. Human Molecular Genetics. 32(10). 1647–1659.

Scoles, Daniel R., Mandi Gandelman, Sharan Paul, et al.. (2022). A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2. Journal of Biological Chemistry. 298(8). 102228–102228. 9 indexed citations

Gandelman, Mandi, Warunee Dansithong, Stephen C. Kales, et al.. (2021). The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy. Journal of Biological Chemistry. 297(4). 101191–101191. 13 indexed citations

Chopra, Ravi, David D. Bushart, Dhananjay Yellajoshyula, et al.. (2020). Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1. Human Molecular Genetics. 29(19). 3249–3265. 14 indexed citations

Gandelman, Mandi, Warunee Dansithong, Karla P. Figueroa, et al.. (2020). Staufen 1 amplifies proapoptotic activation of the unfolded protein response. Cell Death and Differentiation. 27(10). 2942–2951. 32 indexed citations

Brown, Alexander S., Pratap Meera, Ravi Chopra, et al.. (2018). MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias. Proceedings of the National Academy of Sciences. 115(52). E12407–E12416. 20 indexed citations

Scoles, Daniel R. & Stefan M. Pulst. (2018). Spinocerebellar Ataxia Type 2. Advances in experimental medicine and biology. 1049. 175–195. 51 indexed citations

10.

Scoles, Daniel R., et al.. (2017). Molecular dynamics analysis of the aggregation propensity of polyglutamine segments. PLoS ONE. 12(5). e0178333–e0178333. 23 indexed citations

11.

Dansithong, Warunee, Sharan Paul, Karla P. Figueroa, et al.. (2015). Ataxin-2 Regulates RGS8 Translation in a New BAC-SCA2 Transgenic Mouse Model. PLoS Genetics. 11(4). e1005182–e1005182. 64 indexed citations

12.

Scoles, Daniel R., et al.. (2015). Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat. PLoS ONE. 10(6). e0128769–e0128769. 30 indexed citations

13.

Scoles, Daniel R., Gene Hung, Lance Pflieger, et al.. (2014). Treatment Of Spinocerebellar Ataxia Type 2 (SCA2) with MOE Antisense Oligonucleotides (S47.006). Neurology. 82(10_supplement). 1 indexed citations

14.

Elmore, R.G., Yevgeniya Ioffe, Daniel R. Scoles, Beth Y. Karlan, & Andrew J. Li. (2008). Impact of statin therapy on survival in epithelial ovarian cancer. Gynecologic Oncology. 111(1). 102–105. 70 indexed citations

15.

Scoles, Daniel R.. (2007). The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1785(1). 32–54. 71 indexed citations

16.

Scoles, Daniel R., William H. Yong, Yun Qin, Kolja Wawrowsky, & Stefan M. Pulst. (2006). Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c). Human Molecular Genetics. 15(7). 1059–1070. 41 indexed citations

17.

Scoles, Daniel R.. (2000). The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Human Molecular Genetics. 9(11). 1567–1574. 56 indexed citations

18.

Scoles, Daniel R., et al.. (1999). Morphometric separation of annual cohorts within mid-Atlantic bluefish, Pomatomus saltatrix, using discriminant function analysis*. Fishery Bulletin. 97(3). 411–420. 14 indexed citations

19.

Scoles, Daniel R., Bruce B. Collette, & John E. Graves. (1998). Global phylogeography of mackerels of the genus Scomber. Fishery Bulletin. 96(4). 823–842. 63 indexed citations

20.

Scoles, Daniel R., et al.. (1998). Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin. Nature Genetics. 18(4). 354–359. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact